Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ATROVENT HFA
- Role of Parasympathetic Activity in Mild to Moderate Asthma With Irreversible or Fixed Airflow Obstruction
- Mechanisms for Dyspnea on Exertion in Children With Obesity and Asthma: Distinct Physiological Phenotypes
- A Scintigraphy Study of PT010 in COPD Patients
- Ipratropium Bromide Spray as Treatment for Sialorrhea in Children
- Safety and Efficacy of Albuterol Administered by the Halix™ Dry Powder Inhaler in Subjects With Asthma
- Influence of Mechanical Ventilation Modes on the Efficacy of Nebulized Bronchodilator
- Nebulizer Versus Dry Powdered Inhalers for Chronic Obstructive Pulmonary Disease (COPD)
- Phase I, Placebo-Controlled, Blinded Pilot Study of Ipratropium in Children Admitted to the ICU With Status Asthmaticus
- Atrovent in Exercise Induced Laryngeal Obstruction (EILO)
- Ultibro® Versus Spiriva® Alone to Reduce Exertional Dyspnea in Patients With Moderate to Severe COPD
- Ventilation-drive Coupling to Evaluate The Efficacy of Inhaled Bronchodilators in Patients With COPD
- Study of the Comparability of Ipratropium Bromide Hydrofluoroalkane (HFA)-134a Inhalation Aerosol to the Market Standard, Atrovent® Chlorofluorocarbon (CFC) Inhalation Aerosol, in Patients With Chronic Obstructive Pulmonary Disease
- Safety Trial of Atrovent® in Pediatric Patients With Rhinorrhea Associated With a Common Cold or Allergy
- Postmarketing Surveillance Study of Atrovent® Inhalation Solution in Chronic Obstructive Pulmonary Disease
- Postmarketing Surveillance Study of Atrovent® Inhalets in Chronic Obstructive Pulmonary Disease
- Postmarketing Surveillance of Atrovent® in Chronic Obstructive Pulmonary Disease
- Postmarketing Surveillance Study of Atrovent® Inhaletten® in Chronic Obstructive Airways Disease
- Postmarketing Surveillance Study of Atrovent® Inhalets in Chronic Obstructive Airways Disease
- Postmarketing Surveillance Study of Atrovent® in Chronic Obstructive Airways Disease
- Trial to Determine the Comparability of Ipratropium Bromide Hydrofluoroalkane (HFA)-134a Inhalation Aerosol to ATROVENT® Chlorofluorocarbon (CFC) Inhalation Aerosol, in Patients With Chronic Obstructive Pulmonary Disease (COPD)
- Post-marketing Surveillance of Atrovent® Inhalets in Chronic Obstructive Pulmonary Disease
- Post-marketing Surveillance of Atrovent® in Chronic Obstructive Pulmonary Disease
- Safety and Efficacy of Two Different Doses of Ipratropium Bromide Versus ATROVENT® Inhalation Aerosol in Adults With Chronic Obstructive Pulmonary Disease
- Efficacy and Safety of Tiotropium and Atrovent in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
- Comparison of Tiotropium Inhalation Capsules and Atrovent Metered Dose Inhaler (MDI) in a Efficacy and Safety Study in Adults With Chronic Obstructive Pulmonary Disease
- The Effects Of Bronchodilator Therapy On Respiratory And Autonomic Function In Patients With Familial Dysautonomia
- A Pilot Study to Determine the Feasibility and Utility of Implementing of the Full Scale TOM Trial
- Effectiveness of Ipratropium Bromide in Preventing Exercise-induced Bronchoconstriction in Athletes
- WEUKBRE5554: IMI PROTECT(Work Package 2): Beta2 Agonists and Acute Myocardial Infarction
- Efficacy and Tolerability Study in Severe Chronic Obstructive Pulmonary Disease (COPD) Patients
- PT001 MDI Versus Atrovent Study in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
- Combivent Respimat 1-year Safety Study in Patients With Chronic Obstructive Pulmonary Disease
- Study to Assess the Effect of Salbutamol and Ipratropium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients
- Sensitivity of New Exercise Tests in Chronic Obstructive Pulmonary Disease (COPD)
- Study of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room.
- Evaluating Long Acting Beta Agonists Used to Treat Asthma Among Those With Either Arg/Arg or Gly/Gly Genotypes
- Respimat® Combivent Trial in Chronic Obstructive Pulmonary Disease (COPD)
- Budesonide Inhalation Suspension for Acute Asthma in Children
- Efficacy and Safety of Tiotropium Inhalation Capsules and Atrovent MDI in Patients With Chronic Obstructive Pulmonary Disease (COPD)
- Acute Bronchodilator Response of a Single Dose of Atrovent or Berotec on Top of Pharmacodynamic Steady State of Spiriva
- Comparison of Tiotropium and Ipratropium in a Double-Blind, Double-dummy, Efficacy and Safety Study in Adults With COPD
- A Comparison of 18g of Tiotropium Inhalation Capsules Once Daily and Atrovent Metered Dose Inhaler (2 Puffs of 20g, 4 Times Daily) in a Double-Blind, Double-Dummy, Efficacy and Safety Study in Adults With Chronic Obstructive Pulmonary Disease (COPD)
- A Six-week Study Comparing the Efficacy and Safety of Tiotropium Plus Formoterol to Salmeterol Plus Fluticasone in Chronic Obstructive Pulmonary Disease (COPD)
- Effects of Bronchodilators in Mild Chronic Obstructive Pulmonary Disease (COPD)
- Assessment of Ventilation-perfusion Abnormalities in Patients With Stable Smoking-related Airways Disease
- Can Advair and Flovent Reduce Systemic Inflammation Related to Chronic Obstructive Pulmonary Disease (COPD)? A Multi-Center Randomized Controlled Trial
- Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Clinical trials list
click for details